Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reichardt

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
Oncology|June 26, 2004
Setting the record straight: activity of gemcitabine monotherapy for breast cancerPeter Reichardt, David Miles
Seminars in Oncology|March 23, 2011
Clinical experience to date with nilotinib in gastrointestinal stromal tumorsPeter Reichardt, Michael Montemurro
The New England Journal of Medicine|August 15, 2006
Imatinib and altered bone and mineral metabolismHeikki Joensuu, Peter Reichardt
Results and Problems in Cell Differentiation|October 31, 2006
The biophysics of T lymphocyte activation in vitro and in vivoPeter Reichardt, Matthias Gunzer
Cancer|May 11, 2021
An updated review of the treatment landscape for advanced gastrointestinal stromal tumorsShreyaskumar R Patel, Peter Reichardt
Future Oncology (London, England)|June 5, 2015
Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practiceAxel Le Cesne, Peter Reichardt
Expert Review of Anticancer Therapy|June 6, 2009
Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendationsJean-Yves Blay, Peter Reichardt
Onkologie|April 27, 2007
Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patientsPer-Ulf Tunn, Peter Reichardt
Immunological Reviews|July 13, 2007
The molecular makeup and function of regulatory and effector synapsesPeter Reichardt, Bastian Dornbach, Matthias Gunzer
Current Cancer Drug Targets|May 24, 2011
Molecular targeted therapy of gastrointestinal stromal tumorsPeter Reichardt, Annette Reichardt, Daniel Pink
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
Oncology|June 26, 2004
Setting the record straight: activity of gemcitabine monotherapy for breast cancerPeter Reichardt, David Miles
Seminars in Oncology|March 23, 2011
Clinical experience to date with nilotinib in gastrointestinal stromal tumorsPeter Reichardt, Michael Montemurro
The New England Journal of Medicine|August 15, 2006
Imatinib and altered bone and mineral metabolismHeikki Joensuu, Peter Reichardt
Results and Problems in Cell Differentiation|October 31, 2006
The biophysics of T lymphocyte activation in vitro and in vivoPeter Reichardt, Matthias Gunzer
Cancer|May 11, 2021
An updated review of the treatment landscape for advanced gastrointestinal stromal tumorsShreyaskumar R Patel, Peter Reichardt
Future Oncology (London, England)|June 5, 2015
Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practiceAxel Le Cesne, Peter Reichardt
Expert Review of Anticancer Therapy|June 6, 2009
Advanced gastrointestinal stromal tumor in Europe: a review of updated treatment recommendationsJean-Yves Blay, Peter Reichardt
Onkologie|April 27, 2007
Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patientsPer-Ulf Tunn, Peter Reichardt
Immunological Reviews|July 13, 2007
The molecular makeup and function of regulatory and effector synapsesPeter Reichardt, Bastian Dornbach, Matthias Gunzer
Current Cancer Drug Targets|May 24, 2011
Molecular targeted therapy of gastrointestinal stromal tumorsPeter Reichardt, Annette Reichardt, Daniel Pink
Pageof 20